Tom Menzies

Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk

Ruth M. de Tute, Charlotte Pawlyn, David A. Cairns et al. · Journal of Clinical Oncology · 2022 · 79 citations

Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial

Sarah Bird, David A. Cairns, Tom Menzies et al. · Clinical Lymphoma Myeloma & Leukemia · 2021 · 46 citations · Full text

Autologous stem cell transplantation is safe and effective for fit, older myeloma patients: exploratory results from the Myeloma XI trial

Charlotte Pawlyn, David A. Cairns, Tom Menzies et al. · Haematologica · 2020 · 34 citations · Full text

Defining the Optimal Duration of Lenalidomide Maintenance after Autologous Stem Cell Transplant - Data from the Myeloma XI Trial

Charlotte Pawlyn, Tom Menzies, Faith E. Davies et al. · Blood · 2022 · 24 citations

The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from ‘Myeloma <scp>XI’</scp>, a multicentre, open‐label, randomised, phase III trial

Matthew Jenner, Charlotte Pawlyn, Faith E. Davies et al. · British Journal of Haematology · 2022 · 15 citations · Full text